Reference standard for characterization of rosuvastatin

Details Reference standard for characterization of rosuvastatin Reference standard for characterization of rosuvastatin

2007-06-25

2010-06-22

Balasubramanian, Venkataraman (Department: 1624)

Organic compounds -- part of the class 532-570 series

Organic compounds

Four or more ring nitrogens in the bicyclo ring system

C514S267000

Reexamination Certificate

active

07741482

ABSTRACT:
Provided are rosuvastatin degradation products and their use as a reference standard (including reference marker) for analysis of rosuvastatin.

REFERENCES:
patent: 4231938 (1980-11-01), Monaghan et al.
patent: 4346227 (1982-08-01), Terahara et al.
patent: 4444784 (1984-04-01), Hoffman et al.
patent: 4739073 (1988-04-01), Kathawala
patent: 5006530 (1991-04-01), Angerbauer et al.
patent: 5177080 (1993-01-01), Angerbauer et al.
patent: 5260440 (1993-11-01), Hirai et al.
patent: 5354879 (1994-10-01), Konoike et al.
patent: RE37314 (2001-08-01), Hirai et al.
patent: 6316460 (2001-11-01), Creekmore et al.
patent: 6333198 (2001-12-01), Edmeades et al.
patent: 6777552 (2004-08-01), Niddam-Hildesheim et al.
patent: 6858618 (2005-02-01), Raza et al.
patent: 2005/0131066 (2005-06-01), Niddam-Hildesheim et al.
patent: 2005/0222415 (2005-10-01), Kumar et al.
patent: 2007/0191318 (2007-08-01), Kumar et al.
patent: 0 850 902 (1998-07-01), None
patent: 0 521 471 (2000-10-01), None
patent: WO 00/17150 (2000-03-01), None
patent: WO 00/49014 (2000-08-01), None
patent: WO 01/60804 (2001-08-01), None
patent: WO 03/016317 (2003-02-01), None
patent: WO 03/032995 (2003-04-01), None
patent: WO 03/087112 (2003-10-01), None
patent: WO 03/097614 (2003-11-01), None
patent: WO 2004/014872 (2004-02-01), None
patent: WO 2004/052867 (2004-06-01), None
patent: WO 2005/021511 (2005-03-01), None
patent: WO 2006/035277 (2006-04-01), None
patent: WO 2006/079611 (2006-08-01), None
patent: WO 2006 100689 (2006-09-01), None
patent: WO 2006/106526 (2006-10-01), None
patent: WO 2006/136407 (2006-12-01), None
patent: WO 2006/136408 (2006-12-01), None
patent: WO 2007/007119 (2007-01-01), None
Anelli, et al., “Fast and Selective Oxidation Of Primary Alcohols To Aldehydes Or To Carboxylic Acids And Of Secondary Alcohols To Ketones Mediated By Oxoammonium Salts Under Two-Phase Conditions”,J. Org. Chem., 1987, pp. 2559-2562, vol. 52, No. 12.
Hull, et al., “Quantification Of Rosuvastatin In Human Plasma By Automated Solid-Phase Extraction Using Tandem Mass Spectrometric Detection”,Journal of Chromatography B: Biomedical Sciences&Applications, 2002, pp. 219-228, vol. 772, No. 2.
Konoike, et al. “Practical Synthesis of Chiral Synthons for the Preparation of HMG-CoA Reductase Inhibitors” J. Org. Chem., vol. 59, 1994, pp. 7849-7854.
Lenz, et al., “Tetra-N-Propylammonium Perruthenate (TPAP)-Catalysed Oxidations Of Alcohols Using Molecular Oxygen As A Co-Oxidant”,J. Chem. Soc., Perkin Trans. 1, 1997, 3291-3292.
Ley, et al.,Synthesis, 1994, 639-666.
Lipid Research Clinics Program, “The Lipid Research Clinics Coronary Primary Prevention Trial Results: I. Reduction In Incidence Of Coronary Heart Disease”,J.A.M.A., 1984, 351-74, vol. 251, No. 3.
Scandinavian Simvastatin Survival Study Group, “Randomised Trial Of Cholesterol Lowering In 4444 Patients With Coronary Heart Disease: The Scandinavian Survival Study (4s)”,The Lancet, 1994, pp. 1383-1389, vol. 344.
Snyder, et al.,Introduction To Modem Liquid Chromatography, 2nd ed., John Wiley & Sons: New York, 1979, pp. 549, 552, 571-572.
Strobel, et al.,Chemical Instrumentation: A Systematic Approach, 3rded., Wiley & Sons: New York, 1989, pp. 391-393, 879, 894, 922, 924-925, 953.
Wantanabe, et al., “Synthesis And Biological Antivity Of Methanesulfonamide Pyramidine-And N-Methanesulfonyl Pyrrole-Substituted 3,5-Dihydroxy-6-Heptenoates, A Novel Series Of HMG-CoA Reductase Inhibitors”,Bioorganic&Medicinal Chemistry, 1997, pp. 437-444, vol. 5, No. 2.
Witztum, “Chapter 36: Drugs Used In The Treatment Of Hyperlipoproteinemias”,Goodman&Gilman's The Pharmacological Basis Of Therapeutics, 9thed., pp. 875-897.

Affiliated with

Also associated with

Rating

Reference standard for characterization of rosuvastatin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Reference standard for characterization of rosuvastatin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reference standard for characterization of rosuvastatin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4241508